Biogen Idec and Columbia University Medical Center have formed a $30 million strategic alliance to conduct genetics discovery research on the underlying causes of disease and to identify new treatment approaches.
They started medical school in August 2013. Now, Columbia medical students in the Class of 2017 make the transition from classroom studies to instruction in clinical settings.
Preventing two of the most common health care-associated infections—bloodstream infections caused by central lines and pneumonia caused by ventilators—can increase the odds that these patients survive.
